Estée Lauder is in its flop era—skincare sales are down, brands are fading, and they’re cutting jobs. The biggest issue? Zero agility. Once-iconic names feel stale, and new launches aren’t hitting.

D.A. Davidson analyst Linda Bolton Weiser maintained a Buy rating on Prestige Consumer Healthcare (PBH – Research Report) today and set a price ...